Ignite Creation Date:
2024-05-05 @ 11:06 PM
Last Modification Date:
2024-10-26 @ 10:28 AM
Study NCT ID:
NCT01251302
Status:
COMPLETED
Last Update Posted:
2019-01-31
First Post:
2010-11-30
Brief Title:
Utility of a Molecular Personalized Coronary Gene Expression Test Corus CAD or ASGES on Cardiology Practice Pattern
Sponsor:
CardioDx
Organization:
CardioDx
Study Overview
Official Title:
Investigation of a Molecular Personalized Coronary Gene Expression Test on Cardiology Practice Pattern
Status:
COMPLETED
Status Verified Date:
2019-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IMPACT-CARD
Brief Summary:
To investigate whether the use of Corus CAD AgeSexGene Expression score - ASGES blood assay changes the diagnostic testing pattern in patients referred to a cardiologist for the evaluation of chest pain or anginal equivalent symptoms
Detailed Description:
A prospective cohort of 88 subjects receiving the Corus CAD AgeSexGene Expression score - ASGES assay were compared to a retrospective cohort of 83 subjects that did not receive the assay
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| IMPACT-CARD | OTHER | CardioDx | None |